Abstract
Antigenic determinants of Australia antigen (AuAg) may be determined by haemagglutination inhibition with ease and high sensitivity. The reaction depends on the inhibitory effect of the test antigen-positive sample on the agglutination by specific antibody of glutaraldehyde-fixed sheep erythrocytes which have been tanned and coated with AuAg of different specificities. The standard monospecific antibody reactants are directed against one or other of the common antigens, a and Re, or against the subtypic determinants, d, y, w and r. Because it is more sensitive than conventional immunodiffusion or electrosyneresis, and more convenient than radio-immunoassay, haemagglutination inhibition is most suited to large-scale determinations of AuAg subtypes in samples of relatively low antigenic activity.
Full text
PDF![871](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/5bd5875ee558/immunology00322-0125.png)
![872](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/ac01878eceb0/immunology00322-0126.png)
![873](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/e97b26477e2f/immunology00322-0127.png)
![874](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/0b1187a5a16f/immunology00322-0128.png)
![875](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/b5d0e61bee22/immunology00322-0129.png)
![876](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/4d410ba4b8fd/immunology00322-0130.png)
![877](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/ceb5551a974c/immunology00322-0131.png)
![878](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e4/1445685/27b53c93f74f/immunology00322-0132.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bancroft W. H., Mundon F. K., Russell P. K. Detection of additional antigenic determinants of hepatitis B antigen. J Immunol. 1972 Oct;109(4):842–848. [PubMed] [Google Scholar]
- Gerin J. L., Holland P. V., Purcell R. H. Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol. 1971 May;7(5):569–576. doi: 10.1128/jvi.7.5.569-576.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Imai M., Goto A., Nishioka K., Kurashina S., Miyakawa Y. Antigenicity of reduced and alkylated Australia antigen. J Immunol. 1974 Jan;112(1):416–419. [PubMed] [Google Scholar]
- Levene C., Blumberg B. S. Additional specificities of Australia antigen and the possible identification of hepatitis carriers. Nature. 1969 Jan 11;221(5176):195–196. doi: 10.1038/221195a0. [DOI] [PubMed] [Google Scholar]
- Mayumi M., Nakajima M. Letter: Ergasteric hepatitis from tissue with Australia antigen. Ann Intern Med. 1973 Oct;79(4):606–606. doi: 10.7326/0003-4819-79-4-606_1. [DOI] [PubMed] [Google Scholar]
- Nielsen J. O., Le Bouvier G. L. Subtypes of Australia antigen among patients and healthy carriers in Copenhagen. A relation between the subtypes and the degree of liver damage in acute viral hepatitis. N Engl J Med. 1973 Jun 14;288(24):1257–1261. doi: 10.1056/NEJM197306142882401. [DOI] [PubMed] [Google Scholar]
- Vyas G. N., Shulman N. R. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16;170(3955):332–333. doi: 10.1126/science.170.3955.332. [DOI] [PubMed] [Google Scholar]
- Vyas G. N., Williams E. W., Klaus G. G., Bond H. E. Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol. 1972 Apr;108(4):1114–1118. [PubMed] [Google Scholar]